{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:58:38Z","timestamp":1794412718200,"version":"4.9.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research project of Jiangsu Commission of Health","award":["Z2020006"],"award-info":[{"award-number":["Z2020006"]}]},{"name":"Jiangsu Health International Exchange Program","award":["JSH-2018-17"],"award-info":[{"award-number":["JSH-2018-17"]}]},{"name":"Key Medical Talents Program of Wuxi Commission of Health","award":["ZRDC018"],"award-info":[{"award-number":["ZRDC018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The problem of opioid addiction after total hip arthroplasty (THA) has been widely concerned. Tranexamic acid (TXA) has been shown to be effective in reducing blood loss for patients undergoing THA, but few studies focus on its alleviation of postoperative local pain symptoms. The purpose of this study was to investigate whether topical TXA could reduce early postoperative hip pain for primary THA patients, thereby reducing the use of opioids, and whether local pain is related to inflammatory response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this prospective randomized controlled study, we randomly divided 161 patients into a topical group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200979) and an intravenous group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200982). Hip pain was assessed using the visual analogue scale (VAS) score within three days after surgery and tramadol was used for pain relief when necessary. Inflammatory markers such as high-sensitivity C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), interleukin-6 (IL-6), total blood loss and hemoglobin drop were assessed by hematologic tests. The primary outcomes included the VAS score and dose of tramadol from the first to the third day after surgery. The secondary outcomes included the inflammatory markers level, total blood loss and complications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The pain score and inflammation markers level on the first day in the topical TXA group were significantly lower than those in the intravenous TXA group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The correlation analysis showed that the VAS score on the first day after surgery was positively correlated with the inflammation markers level (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The tramadol dose for topical group was lower than intravenous group on the first and second day after surgery. There were no differences in total blood loss between the two groups (640.60\u2009\u00b1\u2009188.12\u00a0ml vs. 634.20\u2009\u00b1\u2009187.85\u00a0ml,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.06). There was no difference in the incidence of complications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Topical use of TXA could relieve the local pain symptoms and reduce opioid consumption compared with intravenous use for patients undergoing primary THA by reduce the early postoperative inflammatory response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The trial was registered at the China Clinical Trial Registry (ChiCTR2100052396) on 10\/24\/2021.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-023-06576-7","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T05:02:02Z","timestamp":1685768522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Topical use of tranexamic acid can reduce opioid consumption compared with intravenous use for patients undergoing primary total hip arthroplasty: a prospective randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Lei","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,3]]},"reference":[{"issue":"1","key":"6576_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13018-020-1565-3","volume":"15","author":"C Changjun","year":"2020","unstructured":"Changjun C, Donghai L, Xin Z, Liyile C, Qiuru W, Pengde K. Mid- to long-term results of modified non-vascularized allogeneic fibula grafting combined with core decompression and bone grafting for early femoral head necrosis. J Orthop Surg Res. 2020;15(1):116.","journal-title":"J Orthop Surg Res"},{"issue":"5","key":"6576_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2106\/JBJS.RVW.17.00103","volume":"6","author":"AL Gianakos","year":"2018","unstructured":"Gianakos AL, Hurley ET, Haring RS, Yoon RS, Liporace FA. Reduction of blood loss by tranexamic acid following total hip and knee arthroplasty: a meta-analysis. JBJS Rev. 2018;6(5):e1.","journal-title":"JBJS Rev"},{"issue":"3","key":"6576_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bpa.2019.07.016","volume":"33","author":"GP Joshi","year":"2019","unstructured":"Joshi GP, Kehlet H. Postoperative pain management in the era of ERAS: an overview. Best Pract Res Clin Anaesthesiol. 2019;33(3):259\u201367.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"8","key":"6576_CR4","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/anae.15498","volume":"76","author":"M Anger","year":"2021","unstructured":"Anger M, Valovska T, Beloeil H, et al. PROSPECT guideline for total hip arthroplasty: a systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2021;76(8):1082\u201397.","journal-title":"Anaesthesia"},{"key":"6576_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.thromres.2019.05.003","volume":"179","author":"N Chornenki","year":"2019","unstructured":"Chornenki N, Um KJ, Mendoza PA, et al. Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: a systematic review and meta-analysis. Thromb Res. 2019;179:81\u20136.","journal-title":"Thromb Res"},{"issue":"6S","key":"6576_CR6","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.1016\/j.arth.2020.01.069","volume":"35","author":"JW Wurtz","year":"2020","unstructured":"Wurtz JW, Wurtz LD, Ziemba-Davis M, Deckard ER, Meneghini RM. Topical tranexamic acid increases early postoperative pain after total hip arthroplasty. J Arthroplasty. 2020;35(6S):S219\u201325.","journal-title":"J Arthroplasty"},{"issue":"9","key":"6576_CR7","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.arth.2020.05.079","volume":"35","author":"Y Lei","year":"2020","unstructured":"Lei Y, Cui D, Huang W. Letter to the editor on \u201ctopical tranexamic acid increases early postoperative pain after total hip arthroplasty.\u201d J Arthroplasty. 2020;35(9):2690.","journal-title":"J Arthroplasty"},{"issue":"4","key":"6576_CR8","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.arthro.2021.10.001","volume":"38","author":"K Goldstein","year":"2022","unstructured":"Goldstein K, Jones C, Kay J, et al. Tranexamic acid administration in arthroscopic surgery is a safe adjunct to decrease postoperative pain and swelling: a systematic review and meta-analysis. Arthroscopy. 2022;38(4):1366-1377.e9.","journal-title":"Arthroscopy"},{"issue":"3","key":"6576_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00000542-198303000-00016","volume":"58","author":"JB Gross","year":"1983","unstructured":"Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983;58(3):277\u201380.","journal-title":"Anesthesiology"},{"issue":"11","key":"6576_CR10","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1016\/j.arth.2020.06.002","volume":"35","author":"AH Goldman","year":"2020","unstructured":"Goldman AH, Griffis CE, Johnson DD, et al. Shifts in prescribers\u2019 initial postoperative opioid prescriptions following primary total hip arthroplasty between 2014 and 2018. J Arthroplasty. 2020;35(11):3208\u201313.","journal-title":"J Arthroplasty"},{"issue":"12","key":"6576_CR11","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1016\/j.arth.2017.08.010","volume":"32","author":"NA Bedard","year":"2017","unstructured":"Bedard NA, Pugely AJ, Dowdle SB, et al. Opioid use following total hip arthroplasty: trends and risk factors for prolonged use. J Arthroplasty. 2017;32(12):3675\u20139.","journal-title":"J Arthroplasty"},{"issue":"4","key":"6576_CR12","doi-asserted-by":"publisher","first-page":"e010664","DOI":"10.1136\/bmjopen-2015-010664","volume":"6","author":"MC Inacio","year":"2016","unstructured":"Inacio MC, Hansen C, Pratt NL, et al. Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open. 2016;6(4):e010664.","journal-title":"BMJ Open"},{"issue":"3","key":"6576_CR13","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.2106\/JBJS.17.01480","volume":"100","author":"NA Bedard","year":"2018","unstructured":"Bedard NA, Sierra RJ, Mabry T. Opioids after orthopaedic surgery: there is a need for universal prescribing recommendations: commentary on an article by Matthew J. Sabatino, MD, MS, et al.: \u201cExcess opioid medication and variation in prescribing patterns following common orthopaedic procedures.\u201d J Bone Joint Surg Am. 2018;100(3):e17.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"6576_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jamasurg.2017.3132","volume":"153","author":"RE Scully","year":"2018","unstructured":"Scully RE, Schoenfeld AJ, Jiang W, et al. Defining optimal length of opioid pain medication prescription after common surgical procedures. JAMA Surg. 2018;153(1):37\u201343.","journal-title":"JAMA Surg"},{"issue":"13","key":"6576_CR15","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e87","volume":"36","author":"Y Cha","year":"2021","unstructured":"Cha Y, Jang SY, Yoo JI, et al. Effect of opioids on all-cause mortality and opioid addiction in total hip arthroplasty: a korea nationwide cohort study. J Korean Med Sci. 2021;36(13): e87.","journal-title":"J Korean Med Sci"},{"issue":"6S","key":"6576_CR16","doi-asserted-by":"publisher","first-page":"S237","DOI":"10.1016\/j.arth.2020.02.014","volume":"35","author":"N Sodhi","year":"2020","unstructured":"Sodhi N, Anis HK, Acu\u00f1a AJ, et al. The effects of opioid use on thromboembolic complications, readmission rates, and 90-day episode of care costs after total hip arthroplasty. J Arthroplasty. 2020;35(6S):S237\u201340.","journal-title":"J Arthroplasty"},{"issue":"14","key":"6576_CR17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2106\/JBJS.17.01414","volume":"100","author":"J Weick","year":"2018","unstructured":"Weick J, Bawa H, Dirschl DR, et al. Preoperative opioid use is associated with higher readmission and revision rates in total knee and total hip arthroplasty. J Bone Joint Surg Am. 2018;100(14):1171\u20136.","journal-title":"J Bone Joint Surg Am"},{"issue":"Suppl 1","key":"6576_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/17453674.2016.1181820","volume":"87 Suppl 1","author":"RS Namba","year":"2016","unstructured":"Namba RS, Inacio MC, Pratt NL, et al. Postoperative opioid use as an early indication of total hip arthroplasty failure. Acta Orthop. 2016;87 Suppl 1(Suppl 1):37\u201343.","journal-title":"Acta Orthop"},{"issue":"3","key":"6576_CR19","doi-asserted-by":"publisher","first-page":"E250","DOI":"10.1503\/cjs.010519","volume":"63","author":"MN Essex","year":"2020","unstructured":"Essex MN, Camu F, Borgeat A, et al. The relationship between postoperative opioid consumption and the incidence of hypoxemic events following total hip arthroplasty: a post hoc analysis. Can J Surg. 2020;63(3):E250\u20133.","journal-title":"Can J Surg"},{"issue":"18","key":"6576_CR20","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.2106\/JBJS.18.01005","volume":"101","author":"HA Prentice","year":"2019","unstructured":"Prentice HA, Inacio M, Singh A, et al. Preoperative risk factors for opioid utilization after total hip arthroplasty. J Bone Joint Surg Am. 2019;101(18):1670\u20138.","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"6576_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/1120700018778240","volume":"29","author":"MJ VanWagner","year":"2019","unstructured":"VanWagner MJ, Krebs NM, Corser W, et al. Liposomal bupivacaine reduces opioid consumption and length of stay in patients undergoing primary total hip arthroplasty. Hip Int. 2019;29(3):276\u201381.","journal-title":"Hip Int"},{"issue":"12","key":"6576_CR22","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1016\/j.arth.2021.08.020","volume":"36","author":"CM Lucero","year":"2021","unstructured":"Lucero CM, Garc\u00eda-Mansilla A, Zanotti G, et al. A repeat dose of perioperative dexamethasone can effectively reduce pain, opioid requirement, time to ambulation, and in-hospital stay after total hip arthroplasty: a prospective randomized controlled trial. J Arthroplasty. 2021;36(12):3938\u201344.","journal-title":"J Arthroplasty"},{"issue":"8","key":"6576_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1302\/0301-620X.99B8.BJJ-2016-1205.R1","volume":"99-B","author":"L Pauzenberger","year":"2017","unstructured":"Pauzenberger L, Domej MA, Heuberer PR, Hexel M, Grieb A, Laky B, et al. The effect of intravenous tranexamic acid on blood loss and early post-operative pain in total shoulder arthroplasty. Bone Joint J. 2017;99-B(8):1073\u20139.","journal-title":"Bone Joint J"},{"issue":"2","key":"6576_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jse.2022.10.007","volume":"32","author":"C Bildik","year":"2023","unstructured":"Bildik C, Pehlivanoglu T. Arthroscopic rotator cuff repair performed with intra-articular tranexamic acid: could it provide improved visual clarity and less postoperative pain? A prospective, double-blind, randomized study of 63 patients. J Shoulder Elbow Surg. 2023;32(2):223\u201331.","journal-title":"J Shoulder Elbow Surg"},{"issue":"8","key":"6576_CR25","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.jse.2021.04.031","volume":"30","author":"H Cui","year":"2021","unstructured":"Cui H, Yu S, Ruan J, Sun Z, Li J, Chen S, et al. Intravenous tranexamic acid reduce postoperative drainage and pain after open elbow arthrolysis: a randomized controlled trial. J Shoulder Elbow Surg. 2021;30(8):1725\u201332.","journal-title":"J Shoulder Elbow Surg"},{"issue":"6","key":"6576_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.otsr.2013.03.029","volume":"99","author":"F Rem\u00e9rand","year":"2013","unstructured":"Rem\u00e9rand F, Cotten M, N\u2019Guessan YF, Couvret C, Rosset P, Favard L, et al. Tranexamic acid decreases risk of haematomas but not pain after hip arthroplasty. Orthop Traumatol Surg Res. 2013;99(6):667\u201373.","journal-title":"Orthop Traumatol Surg Res"},{"issue":"5","key":"6576_CR27","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/pm\/pnab061","volume":"22","author":"P Laumonerie","year":"2021","unstructured":"Laumonerie P, Dalmas Y, Tibbo ME, Robert S, Durant T, Caste T, et al. Sensory innervation of the hip joint and referred pain: a systematic review of the literature. Pain Med. 2021;22(5):1149\u201357.","journal-title":"Pain Med"},{"issue":"3","key":"6576_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3171\/2016.8.SPINE16528","volume":"26","author":"J Kushioka","year":"2017","unstructured":"Kushioka J, Yamashita T, Okuda S, Maeno T, Matsumoto T, Yamasaki R, et al. High-dose tranexamic acid reduces intraoperative and postoperative blood loss in posterior lumbar interbody fusion. J Neurosurg Spine. 2017;26(3):363\u20137.","journal-title":"J Neurosurg Spine"},{"key":"6576_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.artd.2020.12.024","volume":"7","author":"BP Chalmers","year":"2021","unstructured":"Chalmers BP, Mishu M, Cushner FD, Sculco PK, Nguyen J, Westrich GH. Is there a synergistic effect of topical plus intravenous tranexamic acid versus intravenous administration alone on blood loss and transfusions in primary total hip and knee arthroplasties. Arthroplast Today. 2021;7:194\u20139.","journal-title":"Arthroplast Today"},{"issue":"12","key":"6576_CR30","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1111\/jth.14316","volume":"16","author":"D Wang","year":"2018","unstructured":"Wang D, Luo ZY, Yu ZP, et al. The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial. J Thromb Haemost. 2018;16(12):2442\u201353.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"6576_CR31","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1302\/0301-620X.99B11.BJJ-2017-0488.R1","volume":"99-B","author":"J Xie","year":"2017","unstructured":"Xie J, Hu Q, Ma J, Huang Q, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial. Bone Joint J. 2017;99-B(11):1442\u20139.","journal-title":"Bone Joint J"},{"key":"6576_CR32","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1055\/s-0042-1742741","volume":"48","author":"SH Okholm","year":"2022","unstructured":"Okholm SH, Krog J, Hvas AM. Tranexamic acid and its potential anti-inflammatory effect: a systematic review. Semin Thromb Hemost. 2022;48:568.","journal-title":"Semin Thromb Hemost"},{"key":"6576_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.thromres.2019.02.006","volume":"176","author":"S Xu","year":"2019","unstructured":"Xu S, Chen JY, Zheng Q, et al. The safest and most efficacious route of tranexamic acid administration in total joint arthroplasty: a systematic review and network meta-analysis. Thromb Res. 2019;176:61\u20136.","journal-title":"Thromb Res"},{"issue":"1","key":"6576_CR34","doi-asserted-by":"publisher","first-page":"e024350","DOI":"10.1136\/bmjopen-2018-024350","volume":"9","author":"Q Sun","year":"2019","unstructured":"Sun Q, Li J, Chen J, Zheng C, Liu C, Jia Y. Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials. BMJ Open. 2019;9(1):e024350.","journal-title":"BMJ Open"},{"issue":"14","key":"6576_CR35","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2217\/cer-2021-0084","volume":"10","author":"Y Fang","year":"2021","unstructured":"Fang Y, Shang X. Comparison of intravenous versus topical tranexamic acid in primary total hip arthroplasty: a systematic review and meta-analysis of ten randomized trials. J Comp Eff Res. 2021;10(14):1089\u2013102.","journal-title":"J Comp Eff Res"},{"issue":"10","key":"6576_CR36","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1007\/s12325-020-01454-3","volume":"37","author":"X Zhang","year":"2020","unstructured":"Zhang X, Ma D, Wen L, Pan J. Better treatment values in local application of Tranexamic Acid (TXA) than intravenous application with the same dose in total hip arthroplasty. Adv Ther. 2020;37(10):4346\u201355.","journal-title":"Adv Ther"},{"issue":"7","key":"6576_CR37","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.otsr.2019.06.018","volume":"105","author":"J Qiu","year":"2019","unstructured":"Qiu J, Sun X, Zhang W, Ke X, Yang G, Zhang L. Effect of topical tranexamic acid in total hip arthroplasty patients who receive continuous aspirin for prevention of cardiovascular or cerebrovascular events: a prospective randomized study. Orthop Traumatol Surg Res. 2019;105(7):1327\u201332.","journal-title":"Orthop Traumatol Surg Res"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06576-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-023-06576-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06576-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T05:04:05Z","timestamp":1685768645000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-023-06576-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6576"],"URL":"https:\/\/doi.org\/10.1186\/s12891-023-06576-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2552001\/v1","asserted-by":"object"}]},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,3]]},"assertion":[{"value":"5 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Yixing People\u2019s Hospital (No.2020\u2013047), and was registered at Chinese Clinical Trial Registry (ChiCTR2100052396) on 10\/24\/2021. All methods were carried out in accordance with relevant guidelines and regulations. Informed consents were obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"455"}}